Company / Free Cash Flow per Share
Nurix Therapeutics, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.47
FY2025
5-year range
-$3.73 / -$0.03
FY2021-FY2025
Trend
+7.0%
vs FY2024
Sector context
#159 of 192
Health Care
What the data says
Nurix Therapeutics, Inc.'s free cash flow per share of $-3.47 is lower than 83% of companies in the Health Care sector (FY2025). Free Cash Flow per Share has fluctuated over the past 7 years, ranging from $-3.73 in FY2024 to $-0.03 in FY2021.
Based on SEC 10-K filings.
-3.47 in FY2025.
Declined from $-1.90 to $-3.47 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 192This company -$3.47 Sector average $3.32
▼
-204.6% below sector average
Key checks
Key Insights
- In FY2025, free cash flow per share increased 7.0% year-over-year.
- Ranks #159 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2021.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.47 | +7.0% |
| FY2024 | -$3.73 | -96.2% |
| FY2023 | -$1.90 | +5.6% |
| FY2022 | -$2.02 | -7360.6% |
| FY2021 | -$0.03 | +97.9% |
| FY2020 | -$1.29 | -304.1% |
| FY2019 | -$0.32 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026